Hamann J - Search Results

1

Phenotyping primary human microglia: tight regulation of LPS responsiveness.

Melief J, Koning N, Schuurman KG, Van De Garde MD, Smolders J, Hoek RM, Van Eijk M, Hamann J, Huitinga I. Melief J, et al. Among authors: hamann j. Glia. 2012 Oct;60(10):1506-17. doi: 10.1002/glia.22370. Epub 2012 Jun 27. Glia. 2012. PMID: 22740309

2

An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2.

Kwakkenbos MJ, Matmati M, Madsen O, Pouwels W, Wang Y, Bontrop RE, Heidt PJ, Hoek RM, Hamann J. Kwakkenbos MJ, et al. Among authors: hamann j. FASEB J. 2006 Dec;20(14):2582-4. doi: 10.1096/fj.06-6500fje. Epub 2006 Oct 26. FASEB J. 2006. PMID: 17068111

3

The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes.

Matmati M, Pouwels W, van Bruggen R, Jansen M, Hoek RM, Verhoeven AJ, Hamann J. Matmati M, et al. Among authors: hamann j. J Leukoc Biol. 2007 Feb;81(2):440-8. doi: 10.1189/jlb.0406276. Epub 2006 Nov 15. J Leukoc Biol. 2007. PMID: 17108056

4

EMR1, the human homolog of F4/80, is an eosinophil-specific receptor.

Hamann J, Koning N, Pouwels W, Ulfman LH, van Eijk M, Stacey M, Lin HH, Gordon S, Kwakkenbos MJ. Hamann J, et al. Eur J Immunol. 2007 Oct;37(10):2797-802. doi: 10.1002/eji.200737553. Eur J Immunol. 2007. PMID: 17823986 Free article.

5

Analysis of CD97 expression and manipulation: antibody treatment but not gene targeting curtails granulocyte migration.

Veninga H, Becker S, Hoek RM, Wobus M, Wandel E, van der Kaa J, van der Valk M, de Vos AF, Haase H, Owens B, van der Poll T, van Lier RA, Verbeek JS, Aust G, Hamann J. Veninga H, et al. Among authors: hamann j. J Immunol. 2008 Nov 1;181(9):6574-83. doi: 10.4049/jimmunol.181.9.6574. J Immunol. 2008. PMID: 18941248

6

GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo.

van Olffen RW, Koning N, van Gisbergen KP, Wensveen FM, Hoek RM, Boon L, Hamann J, van Lier RA, Nolte MA. van Olffen RW, et al. Among authors: hamann j. J Immunol. 2009 Jun 15;182(12):7490-500. doi: 10.4049/jimmunol.0802751. J Immunol. 2009. PMID: 19494272

7

Deletion of either CD55 or CD97 ameliorates arthritis in mouse models.

Hoek RM, de Launay D, Kop EN, Yilmaz-Elis AS, Lin F, Reedquist KA, Verbeek JS, Medof ME, Tak PP, Hamann J. Hoek RM, et al. Among authors: hamann j. Arthritis Rheum. 2010 Apr;62(4):1036-42. doi: 10.1002/art.27347. Arthritis Rheum. 2010. PMID: 20131275 Free article.

8

Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease.

van Eijk M, Aust G, Brouwer MS, van Meurs M, Voerman JS, Dijke IE, Pouwels W, Sändig I, Wandel E, Aerts JM, Boot RG, Laman JD, Hamann J. van Eijk M, et al. Among authors: hamann j. Immunol Lett. 2010 Apr 8;129(2):64-71. doi: 10.1016/j.imlet.2010.02.004. Epub 2010 Feb 16. Immunol Lett. 2010. PMID: 20167235

9

Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation.

Koning N, van Eijk M, Pouwels W, Brouwer MS, Voehringer D, Huitinga I, Hoek RM, Raes G, Hamann J. Koning N, et al. Among authors: hamann j. J Innate Immun. 2010;2(2):195-200. doi: 10.1159/000252803. Epub 2009 Oct 22. J Innate Immun. 2010. PMID: 20375636 Free article.

10

The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?

Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, Kastelein JJ, Hamann J, Goffin V, von der Thüsen JH, Twickler MT, Aten J. Reuwer AQ, et al. Among authors: hamann j. J Endocrinol. 2011 Feb;208(2):107-17. doi: 10.1677/JOE-10-0076. Epub 2010 Nov 10. J Endocrinol. 2011. PMID: 21068074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page